MOLECULAR PROFILE AND ANTI-TUMOR ACTIVITY IN NON-SMALL CELL LUNG CANCER (NSCLC) PATIENTS (PTS) IN A PHASE 1 STUDY OF CABOZANTINIB (XL184) IN JAPAN

被引：0
作者：
Nokihara, H. [1 ]
Yamamoto, N. [1 ]
Nakamichi, S. [1 ]
Wakui, H. [1 ]
Yamada, Y.
Frye, J. [2 ]
Decillis, A. [2 ,3 ]
Tamura, T. [4 ]
机构：
[1] Natl Canc Ctr, Div Thorac Oncol, Tokyo, Japan
[2] Exelixis Inc, Med Affairs, San Francisco, CA USA
[3] Exelixis Inc, Clin Dev, San Francisco, CA USA
[4] Natl Canc Ctr, Div Internal Med & Thorac Oncol, Tokyo, Japan
来源：
ANNALS OF ONCOLOGY | 2012年 / 23卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：174 / 174
页数：1
相关论文
共 50 条
  • [31] Biomarker analyses from a phase I study of pertuzumab combined with erlotinib in patients (pts) with non-small cell lung cancer (NSCLC)
    Felip, E.
    Ranson, M.
    Cedres, S.
    Brewster, M.
    Mcnally, V.
    Venturi, M.
    Passioukov, A.
    Ross, G.
    Galdermans, D.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
  • [32] Phase II study of mitonafide in non-small cell lung cancer (NSCLC)
    Casado, A
    Rosell, R
    GarciaGomez, R
    DiazRubio, E
    PerezManga, G
    Font, A
    Benavides, A
    Martin, M
    [J]. INVESTIGATIONAL NEW DRUGS, 1996, 14 (04) : 415 - 417
  • [33] Pharmacokinetic (PK) profile of quisinostat in combination with gemcitabine and cisplatin in patients (pts) with non-small cell lung cancer (NSCLC) or paclitaxel and carboplatin in pts with NSCLC or epithelial ovarian cancer
    Fedyanin, M.
    Tjulandin, S.
    Cheporov, S.
    Vladimirov, V.
    Moiseenko, V.
    Orlov, S.
    Manikhas, G.
    Koryakova, A.
    Cakana, A.
    Phelps, C.
    Baranovsky, S.
    Azarova, V.
    Karavaeva, O.
    Vostokova, N.
    [J]. EUROPEAN JOURNAL OF CANCER, 2017, 72 : S96 - S96
  • [34] Phase II and pharmacogenetic study of docetaxel (D) and capecitabine (C) in chemonaive non-small cell lung cancer (NSCLC) patients (pts)
    Lustberg, M. B.
    Bekaii-Saab, T. S.
    Diasio, R.
    Ezzeldin, H.
    Starrett, S. L.
    Otterson, G. A.
    Villalona, M. A.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)
  • [35] Phase II study of crizotinib in east Asian patients (pts) with ROS1-positive advanced non-small cell lung cancer (NSCLC).
    Goto, Koichi
    Yang, James Chih-Hsin
    Kim, Dong-Wan
    Lu, Shun
    Seto, Takashi
    Yang, Jin-Ji
    Yamamoto, Noboru
    Ahn, Myung-Ju
    Takahashi, Toshiaki
    Yamanaka, Takeharu
    Kemner, Allison Margaret
    Roychowdhury, Debasish
    Paolini, Jolanda
    Wilner, Keith D.
    Wu, Yi-Long
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (15)
  • [36] Phase ii trial with Docetaxel in patients (PTS) with non small cell lung cancer (NSCLC)
    Latreille, J
    Laberge, F
    Viallet, J
    Maksymiuk, A
    Shepherd, F
    Gelman, K
    Delorme, F
    [J]. EUROPEAN JOURNAL OF CANCER, 1995, 31A : 1070 - 1070
  • [37] Concentration-dependent early anti-vascular and anti-tumor effects of itraconazole in non-small cell lung cancer (NSCLC)
    Gerber, David E.
    Fattah, Farjana J.
    Brekken, Rolf A.
    Skelton, Rachael
    Saltarski, Jessica
    Ahn, Chul
    Kernstine, Kemp H.
    Padmanabhan, Chyndhri
    Chemburkar, Vaidehi
    Kasiri, Sahba
    Kallem, Rajareddy
    Subramaniyan, Indhumathy
    Yuan, Qing
    Do, Quyen N.
    Xi, Yin
    Pedrosa, Ivan
    Putnam, William C.
    Kim, James
    [J]. CANCER RESEARCH, 2019, 79 (13)
  • [38] Whole Exome Sequencing to Profile the Genomic Landscapes of Young Patients (pts) Diagnosed with Non-Small Cell Lung Cancer (NSCLC)
    Ma, Patrick C.
    Feng, Yan
    Varadan, Vinay
    Wu, Xiaoliang
    Fink, Stephen
    Zhang, Wei
    Yin, Lihong
    Liu, Angen
    Remick, Scot
    Zhang, Zhenfeng
    Guda, Kishore
    [J]. JOURNAL OF THORACIC ONCOLOGY, 2015, 10 (09) : S217 - S217
  • [39] A molecular profile that predicts response to platinum based chemotherapy in non-small cell lung cancer (NSCLC) patients
    Petty, RD
    Murray, GI
    Kerr, K
    Nicolson, MC
    Bissett, JD
    Collie-Duguid, E
    [J]. BRITISH JOURNAL OF CANCER, 2004, 91 : S14 - S14
  • [40] Cobolimab With Dostarlimab and Docetaxel in Patients (pts) With Advanced Non-small Cell Lung Cancer (NSCLC): COSTAR Lung
    Kim, Hye Ryun
    Gridelli, Cesare
    Kapur, Dinesh
    Tufman, Amanda
    Felip, Enriqueta
    Velcheti, Vamsidhar
    Kim, Yu Jung
    Goetze, Thorsten
    Lopez, Pilar Garrido
    Corre, Romain
    Penkov, Konstantin
    Anjum, Rana
    Di Pace, Brian
    Liu, Wenlei
    Borgovan, Theo
    Ledger, Danielle
    Carver, Jennifer
    Waszak, Angela
    Dhar, Arindam
    Novello, Silvia
    [J]. ONCOLOGY RESEARCH AND TREATMENT, 2022, 45 (SUPPL 3) : 163 - 163
12345